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Abstract
Obesity and its related health complications cause billions of dollars in healthcare costs annually 
in the United States, and there are yet to be safe and long-lasting anti-obesity approaches. Using 
brown adipose tissue (BAT) is a promising approach, as it uses fats for energy expenditure. 
However, the effect of the microenvironment on human thermogenic brown adipogenesis and how 
to generate clinically relevant sized and functioning BAT are still unknown. In our current study, 
we evaluated the effects of endothelial growth medium exposure on brown adipogenesis of human 
brown adipose progenitors (BAP). We found that pre-exposing BAP to angiogenic factors 
promoted brown adipogenic differentiation and metabolic activity. We further 3D bioprinted 
brown and white adipose progenitors within hydrogel-based bioink with controllable 
physicochemical properties and evaluated the cell responses in 3D bioprinted environments. We 
used soft, stiff, and stiff-porous constructs to encapsulate the cells. All three types had high cell 
viability and allowed for varying levels of function for both white and brown adipocytes. We 
found that the soft hydrogel constructs promoted white adipogenesis, while the stiff-porous 
hydrogel constructs improved both white and brown adipogenesis and were the optimal condition 
for promoting brown adipogenesis. Consistently, stiff-porous hydrogel constructs showed higher 
metabolic activities than stiff hydrogel constructs, as assessed by 2-deoxy glucose uptake (2-DOG) 
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and oxygen consumption rate (OCR). These findings show that the physicochemical environments 
affect the brown adipogenesis and metabolic function, and further tuning will be able to optimize 
their functions. Our results also demonstrate that 3D bioprinting of brown adipose tissues with 
clinically relevant size and metabolic activity has the potential to be a viable option in the 
treatment of obesity and type 2 diabetes.
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Tissue engineering; Brown adipocytes; Obesity; Stiffness; Porosity
1. Introduction
Obesity and its related health issues are major concerns in the United States health care 
system. The obesity-mediated health complications, such as type 2 diabetes mellitus 
(T2DM), cause $190 billion in healthcare costs annually in the United States [1]. One 
promising strategy for the treatment or prevention of obesity-mediated health complications 
is augmenting brown adi-pose tissue (BAT) thermogenesis. BAT is a specialized fat that 
actively disposes of glucose and fatty acids from circulation by dissipating the mitochondrial 
proton gradient into heat through uncoupling protein-1 (UCP1) [2,3]. Recent advances in our 
understanding of BAT in humans have provided a new insight into weight loss strategies, as 
well as metabolic improvement [4,5]. Humans possess a substantial amount of energy-
burning brown/beige fat, especially in the neck and supraclavicular area [6,7]. It is estimated 
that brown/beige fat could be responsible for >20% of daily energy expenditure in healthy 
humans [8]. Since increased BAT mass/activity significantly improves glucose and lipid 
home-ostasis, BAT has garnered attention as a therapeutic intervention for obesity and 
T2DM [9]. However, activation or induction of BAT thermogenesis shows negative 
regulation with BMI, body fat content, visceral fat, age, and plasma glucose levels [10–14]. 
In addition, induction of BAT by a pharmacological dose of β3-agonists failed to help the 
weight loss of obese individuals [15–17]. It is worthwhile to notice that restoration of BAT 
by implanting BAT from healthy donor mice to diabetic recipient mice can effectively 
reverse T2DM and other metabolic disorders [18,19]. These results support that BAT 
transplantation is a promising and alternative approach to combat obesity and type 2 
diabetes utilizing BAT energetics.
There are at least three different types of adipocytes found in humans: white adipocytes 
(WA) that are mainly involved in energy storage, classical brown adipocytes that share 
myogenic origin (myogenic factor 5 positive-Myf5+), and beige adipocytes that have the 
same cellular origin as white adipocytes (Myf5[−]) [20,21]. Beige adipocytes express 
transient levels of UCP1 upon external thermogenic stimuli, while classical brown 
adipocytes possess constitutively active UCP1 expression, suggesting an ideal cell 
preparation for transplantation [22,23]. The effects of physico-chemical microenvironments 
on white adipocyte culture [24] and white adipogenic differentiation of mesenchymal stem 
cells [25,26] have been widely studied. For example, Pellegrinelli et al. studied the role of 
mechanotransduction of the extracellular matrix on human WA, where a 3D decellularized 
extracellular matrix hydrogel was developed and a mechanical compression was applied to 
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the WA [27]. There are several studies on generating 3D beige adipocyte cultures using 
adipogenic mesenchymal stromal vascular cells or bone marrow-derived non-hematopoietic 
cells from humans [28]. By using murine adi-pose derived stem cells, Tharp et al 
demonstrated that the implantation of scaffold-assisted 3D-BAT successfully elevated core 
body temperature during cold challenges, improved glucose homeostasis, and reduced 
weight gain, compared to the hydrogel control[29]. However, very few studies have been 
conducted to generate 3D cultures from human classical brown precursor cells (BAP), due to 
the lack of appropriate cell models and difficulties in the isolation of human BAP. 
Considering the metabolic differences of human and rodent brown fat biology, it is an 
important gap to fill, because the implementation of BAT transplantation is a promising 
therapy for the treatment of obesity.
BAT is a highly innervated tissue with a well-organized vasculature system [30]. 
Maintenance of a capillary network is critically important for its metabolic function as well 
as survival of engrafted tissue. There is increasing evidence that angiogenic factors modu 
late the brown/beige differentiation and its survival after transplantation [31,32]. On the 
other hand, the microenvironment of the 3D culture conditions, such as stiffness or porosity 
of the matrix, have shown to affect the behavior of the white adipocytes [33–35]. Therefore, 
the modulation of both BAP and the matrix hydrogel formulation would be important factors 
to consider for generating metabolically active 3D BAT depots for implantation.
To obtain physiological relevance to humans, we used the BAP established from humans in 
comparison with white adipose progenitor cells (WAP) [36]. In this study, we first optimized 
the early differentiating conditions of human BAP into functional brown adipocytes (BA). 
By using the optimized culture conditions, our primary goal was to generate 3D bioprinted 
adipose constructs that have clinically relevant size and are applicable for implantation. Our 
study demonstrated that tuning the stiffness and porosity of an HA-based hydrogel matrix 
regulates the metabolic functions of 3D BAT. Our work will provide an important insight 
into implementing the 3D BAT strategy to potentiate the metabolic function in humans.
2. Materials and methods
2.1. Maintenance and differentiation of human white- and brown-progenitor cell-lines
Immortalized human WAP and BAP were a generous gift from Dr. Yu-Hua Tseng at the 
Joslin Diabetes Center, Harvard Medical School. In detail, primary stromal vascular cells, 
isolated from either subcutaneous fat or neck brown fat from one anonymous female (subject 
5), were infected with retrovirus expressing hTERT [36]. The selected immortalized cells 
were grown and maintained in DMEM with 10% FBS and 1% Pen/Strep (Gibco). To 
optimize the brown differentiation potential, brown precursor cells were grown in either 
DMEM or endothelial growth medium (EGM) (Lonza) before differentiation. For adipocyte 
differentiation, we followed the published protocol [36].
2.2. Polymer modification and hydrogel bioink preparation
Photocrosslinkable hyaluronic acid (HA, NovaMatrix, ~1200 kDa) and gelatin (Gel, from 
bovine skin, Sigma) were synthesized as previously reported through the reaction of 
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methacrylic anhydride (Sigma) in deionized water [37]. For bioink preparation, 
methacrylated HA (Me-HA, 1.5%w/v), methacrylated gelatin (Me-Gel, 1.5%w/v), HA 
(3%w/v), and gelatin (3% w/v) were dissolved in cell culture medium with a cell suspension 
(5 106 cells/ml) and 0.05% w/v 2-hydroxy-1(4-(hydroxyethyl)phenyl)-2-methyl-1-
propanone (Irgacure 2959; CIBA Chemicals). HA and gelatin, without modification, were 
used to increase the viscosity and printability and to maintain the softness of the bioprinted 
constructs for cell spreading.
2.3. 3D bioprinting and characterization of bioprinted constructs
Prior to 3D bioprinting, BAP were expanded with EGM medium, while white precursor cells 
were maintained in DMEM medium as described in 2.1. For the 3D bioprinting with the 
hydrogel bioinks, the gel precursors with cells were loaded into the deposition syringes 
(Nordson EFD) with 22G metal tips, extruded by the 3D bio-printer (3D Bioplotter, 
EnvisionTEC, Germany) based on the disc shaped design (∅8 mm × 1.2 mm), and 
subsequently exposed to an OmniCure S2000 UV lamp (Lumen Dynamics) for 30 or 90 s at 
room temperature. The bioprinting pattern was printed as to make solid discs (denoted as 
soft solid and stiff solid), as well as in lines spaced 0.8 mm apart, as to create porous discs 
with 90 s photocrosslink (denoted as stiff porous) (Fig. 2A). The stiffnesses of the bioprinted 
hydrogel discs were measured using a compression tester (Agilent T150 UTM) at room 
temperature. The compressing speed was 5 mm/min, and the raw load was set to be 540 mN. 
For surface morphology observation, the bioprinted constructs were washed with deionized 
water and were lyophilized for 3 days then sputter coated with gold for SEM (FEI Quanta 
200) imaging. The 3D printed stiff-porous constructs were also imaged by using a Zeiss 
Discovery v8 stereo microscope.
2.4. Differentiation of 3D WAP and BAP constructs
After bioprinting, all gels were placed in growth medium (GM) for one day. After that, the 
cell-laden constructs were placed in differentiation medium, consisting of DMEM with 2% 
FBS, 1% Pen/Strep, 0.5 μM recombinant human insulin (Alfa Aesar), and 2 nM tri-
iodothyronine (T3, Sigma) for 6 days, with medium changed every 3 days. Induction was 
further conducted after 6 days of differentiation by using induction medium (IM) for another 
12 days. Induction medium consisted of differentiation medium, 33 μM biotin (Sigma), 17 
μM pantothenate (Sigma), 0.1 μM dexamethasone (Sigma), 500 μM 3-isobutyl-1-methyl 
xanthine (IBMX, Sigma), and 30 lM indomethacin (Sigma).
2.5. Cell viability
The viability and circularity of encapsulated cells was determined using a Live/Dead assay 
(Invitrogen) after differentiation and induction as previously described [38], and 
fluorescence images were obtained using a confocal laser scanning microscope (CLSM, 
LSM 710, Carl Zeiss). Cell viability was semi-quantitatively measured via counting live 
(green) and dead (red) cells based on Live/Dead images (at least six images were analyzed 
for each hydrogel sample), using ImageJ [39].
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2.6. Immunofluorescence (IF) staining
For IF staining, the constructs were fixed in 4% paraformalde-hyde, permeabilized in 0.2% 
Triton X-100, and then blocked with 1% bovine serum albumin (BSA) overnight at 4 °C. 
The samples were incubated in the primary antibody to UCP1 (1:100, Abcam) overnight at 
4 °C. Secondary fluorescent antibodies for UCP1 (1:100), and/or BODIPY® (10 μg/ml, 
Thermo Scientific) were incubated for 2 h, and nuclear counterstaining (via Draq 5, 1:1000, 
Biostatus) were performed for 30 min at room temperature. Then samples were imaged with 
a Zeiss 710 CLSM. Lipid droplets were identified as round structures that were stained by 
BODIPY®. The lipid density and lipid droplet size were measured and calculated by 
analyzing nine images from three samples using ImageJ software. Lipid density was 
calculated by comparing total lipid (green) area with total cells in the images.
2.7. Western blot
Total cell extracts were prepared as described previously [40]. Proteins were fractionated 
using 4–15% precast polyacrylamide gel (Bio-Rad) and transferred to PVDF membranes 
with a semi-dry transfer unit (Hoefer TE77X). Antibody targeting UCP1 (#14670), 
HDAC1(#34589), histone 3 (H3, 4499) and β-actin (4967) were purchased from Cell 
Signaling Technology. Blots were visualized with FluorChem™E imaging system (Protein 
Simple).
2.8. RNA isolation and quantitative real time polymerase chain reaction (qPCR)
For qPCR analysis, the samples were first homogenized in lysis buffer using a bead miller 
(Fisher Scientific). Total RNA was extracted from the cell-laden constructs using QIA-
Shredder and RNeasy mini-kits (QIAgen), according to the manufacturers’ instructions. 
Total RNA was synthesized into first strand cDNA in a 20 μL reaction using an iScript 
cDNA synthesis kit (BioRad Laboratories). Real-time PCR analysis was performed in a 
StepOnePlus™ Real-Time PCR System (Thermo Scientific) using SsoAdvanced SYBR 
Green Supermix (Bio-Rad). cDNA samples were analyzed for the gene of interest and for 
the housekeeping gene 18S rRNA. The level of expression of each target gene was 
calculated using the comparative Ct (2−ΔΔct) method. For microRNA analysis, we followed 
the protocol that we have described previously [41].
2.9. Oxygen consumption rate (OCR)
To determine the mitochondrial respiration activities, the O2 concentration in the cells was 
measured using XF24 extracellular flux analyzer (Seahorse) as we conducted previously 
[41]. Briefly, human BAP were seeded in gelatin-coated seahorse microplate (24-well) until 
reached confluence followed by brown differentiation. The cells were then treated with 
oligomycin (oligo, 1 μM) to measure the ATP turnover. The maximum respiratory capacity 
was assessed by addition of carbonyl cyanide 4-trifluoromethoxy phenylhydrazone (FCCP, 
0.3 μM), a chemical uncoupler of electron transport and oxidative phosphorylation. The 
mitochondrial respiration was blocked by antimycin A (1 μM) plus rotenone (1 μM) (A + 
R). The oxygen consumption rate (OCR) was calculated by plotting the O2 tension of the 
medium in the microenvironment above the cells as a function of time (pmol O2/minutes). 
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Similar procedures were performed to measure the OCR of 3D-BA constructs to compare 
the metabolic function of stiff-porous vs. stiff hydrogel printing conditions.
2.10. 2-deoxy glucose uptake (2-DOG)
The engineered human 3D WA and BA constructs were tested for glucose uptake by using 2-
deoxy glucose (2DOG) (Perkin Elmer) as a tracer. Prior to the glucose uptake test, the 
differentiated 3D-WA or BA constructs were first incubated in 6 well plates with 1 mL of 
serum-free low glucose DMEM, containing 1 g/L D-(+)-glucose and 20 pM human insulin 
for 24 h. Culture media was removed and replaced with 1 mL of HBSS buffer in the 
presence or absence of 100 nM human insulin for 10 min. Next, 4 nmol of [3H]-2-
deoxyglucose (Perkin Elmer) was added into each well. Then cellular uptakes were 
measured over 90 min, and the [3H]-associated radioactivity was measured by a liquid 
scintillation counter.
2.11. Statistical analysis
All quantitative data was expressed as mean ± standard deviation (SD). Pairwise 
comparisons between groups were conducted using ANOVA with Scheffé post-hoc tests. A 
p-value of <0.05 was considered statistically significant.
3. Results
3.1. Prior exposure of human BAP to angiogenic factors promoted brown differentiation 
and metabolic activities.
The environmental factors that alter brown fat development in humans have not been clearly 
established yet. Before we used the human BAP for 3D bioprinting, we first optimized the 
growing conditions of BAP. Given the intimate relationship between brown adipogenesis 
and capillary network in vivo, we hypothesize that angiogenic factors, such as vascular 
endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2), modulate brown 
adipogenic potential. Immortalized classical BAP from human, were pre-exposed in EGM 
containing VEGF and FGF2 for 48 h before brown adipogenic stimulation. Pre-exposure to 
EGM resulted in approximately a 10-fold increase of the brown signature gene, Ucp1, 
expression compared to BA maintained in DMEM, and a slight, but significant, increase of 
classical brown specific marker Zic1 and VEGF receptor 1 (Vegfr-R1) (Fig. 1A). It is also 
notable that a robust increase of Pgc1α, a transcriptional regulator for mitochondrial 
biogenesis, and a decrease of Hdac1, which is a negative regulator of the brown adipocyte 
[42] (Fig. 1A). Consistently, there was increased UCP1 but decreased HDAC1 protein levels 
(Fig. 1B), suggesting that pre-exposure to EGM causes an epigenetic modification favorable 
to brown differentiation. In addition, pre-exposure to EGM medium robustly increased both 
basal- and uncoupled-respiration, determined via a Seahorse XF analyzer (Fig. 1C). To 
further understand the mechanism by which prior exposure to antigenic factors alters brown 
adipogenesis, we also examined the key miRNA regulators promoting brown transcriptional 
programming. As we expected, biogenesis of functional clusters of brown-specific 
microRNAs, i.e., miR-378, miR-30b, and miR-193b/365, were significantly higher than cells 
grown in the control DMEM medium (Fig. 1D). Taken together, we demonstrated that prior 
exposure to angiogenic environment promotes the cell-autonomous potential to convert 
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brown precursor cells into metabolically active human brown adipocytes via epigenetic 
mechanisms. By taking advantage of this pre-conditioning of BAP with angiogenic 
regulators, we next modulated the conditions for matrix formulation that support 3D BAT 
differentiation and brown function.
3.2. 3D bioprinting of WA and BA within bioinks with tunable stiffness and structure
We implemented Me-HA/Me-Gel based bioinks to encapsulate WAP and BAP and 3D 
bioprinted them into disc-shaped constructs. The stiffness was tuned by varying the 
photocrosslinking time, and the pore structure was achieved by depositing the lines with pre-
designed spacing between each other (Fig. 2A). The stiffness for the constructs with 30-
second photocrosslinking (soft solid) was 2.02 ± 1.11 kPa, which was significantly lower 
than that for 90-second photocrosslinking (9.17 ± 3.14 kPa for stiff solid, and 9.00 ± 2.38 
kPa for stiff porous), regardless of the structure (Fig. 2B). Fig. 2C shows the SEM and 
optical images of the 3D bioprinted constructs. The hydrogel based constructs had 
interconnected, macro-porous structures after the ice crystals were removed by freezing and 
freeze drying. As expected, the pore size was larger for the soft, solid hydrogel constructs 
compared to their stiff counterparts. The stiff, porous constructs showed a well-maintained 
porous grid structure. Both encapsulated WAP and BAP showed high cell viability, with 
most cells stained with calcein (green) after differentiation/induction (Fig. 3A and B). In 
addition, the stiffness and porosity did not apparently affect cell viability (Fig. 3C). For the 
stiff, porous group, although some pores were blocked, probably due to hydrogel collapse, 
degradation, and cell confluence on the surface, most of pores were visible, which allowed 
for a higher surface area for nutrient transfer in the constructs (Fig. 3A and B).
3.3. Soft and porous 3D bioprinted constructs promoted white adipogenesis
Fig. 4A shows the lipid staining images from bioprinted WAP within soft or stiff bioinks 
with solid or porous structures. In all of the conditions, lipid production was observed 
around the nuclei of the cells, even in the constructs conditioned in GM. Although all of the 
constructs showed lipid accumulation, it seemed that the soft, 30-second crosslinked 
constructs, and porous constructs allowed for larger lipid droplet size and higher lipid 
density compared to the 90-second crosslinked constructs after induction (Fig. 4B, C). 
However, there was no statistic difference, based on the image analysis. In order to 
determine white adipogenic gene expression of 3D bioprinted WAP laden constructs, qPCR 
analysis was conducted after conditioning in GM or IM (Fig. 4D). The soft, solid and stiff, 
porous constructs in IM conditions showed the highest Pgc1α gene expression, with the soft 
gels being the highest. Both of these showed a significant difference between them and the 
GM condition. The soft, induction gels also showed significant upregulation of Pgc1α gene 
compared to stiff, induction gels. Similarly, the CCAAT/enhancer-binding protein 2 (C/
EBP-2) gene (bio-marker for early stages of adipogenesis) expression in the soft, solid and 
stiff, porous gels with induction were the highest and very similar, which were significantly 
higher than that for soft, solid constructs in GM. The stiff, porous constructs, after induction, 
had the highest fatty acid binding protein 4 (Fabp4, late marker of adipogenesis) expression, 
which was significantly higher than that for soft, solid constructs in GM and stiff, solid 
constructs in IM.
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3.4. Porous 3D bioprinted constructs promoted brown adipogenesis
Then we 3D bioprinted BAP-laden constructs with different stiffnesses and structures and 
conditioned them in GM or IM, similar to WAP-laden constructs, which served as a control. 
Fig. 5A shows the staining of lipid droplets and UCP1. In all instances, lipid production was 
observed around the BA, even in the GM. However, BAP-laden constructs in GM expressed 
very limited UCP1, while after induction, the constructs seemed to have a good amount of 
UCP1 production, especially for the stiff, porous constructs (Fig. 5A). QPCR results showed 
that the expression of cell death-inducing DFFA-like effector A (Cidea), which plays a role 
in thermo-genesis and lipolysis [43], is significantly higher in the WAP-laden constructs 
after induction (Fig. 5B). BA in the stiff, porous constructs showed the highest Cidea 
expression, which was statistically significant when compared to their BAP and WAP-laden 
counterpart constructs (Fig. 5B). All of the 3D BAP constructs showed much higher Prdm16 
gene expression than their WAP counterparts, as shown in Fig. 5B. Prdm16 is highly 
enriched in BAP compared to WAP [44]. Other than the porous gels, the white adipose gels 
showed limited Prdm16 expression. The soft BAP constructs in IM had low expression, 
while the stiff and porous ones showed very high Prdm16 expression, which were 
significantly higher than the rest of the constructs and were similar to each other. For Ucp1 
gene expression, similar to Prdm16, all of the WAP-laden constructs had minimal and much 
less Ucp1 expression, compared to BAP laden constructs. The expression in the BAP 
constructs with GM conditioning was also relatively low. The other three brown adipose gel 
conditions had higher Ucp1 expression, especially for soft, solid and stiff, porous constructs 
with induction. We also evaluated the gene expression of some inflammatory markers [i.e. 
interleukin 6 (Il6), nitric oxide synthase 2 (Nos2), Tumor necrosis factor alpha (Tnfα)] in 
the bioprinted BAP constructs after induction (Fig. 5C). The BAP in the stiff-solid 
constructs significantly upregulated the expression of Il6 and Nos2 compared to the soft-
solid constructs, but their expressions were downregulated in the stiff-porous constructs. 
This indicates that the rigidity of the microenvironment may cause inflammatory effects, and 
the porous structure, with facilitated diffusion and transportation, may counteract the 
inflammatory effects of the rigidity of the environment.
By using these differentially bioprinted 3D BAP constructs, we next evaluated their 
metabolic function of by measuring 2-DOG. As we expected, 3D BAP-laden constructs 
showed a robustly higher glucose uptake compared to their WAP counterparts (Fig. 6A). 
Intriguingly, 3D cultures with soft gel conditions (i.e., 30 s UV crosslinking) showed lower 
glucose uptake than stiff gel conditions (90 s UV crosslinking). The same stiffness with 
porous structure significantly increased the 2-DOG uptake (Fig. 6A), suggesting that the 
stiff, porous gel group is superior to other groups for glucose uptake. In agreement with this 
result, the OCR was higher in 3D cultures with stiff-porous hydrogel conditions than the 3D 
cultures with the same stiffness without porosity modulation (Fig. 6B). Next, we examined 
whether increased porosity of the 3D matrix will also be beneficial for insulin-stimulated 
glucose uptake. Insulin stimulation (100 nM) promoted glucose uptake in both conditions of 
3D BAP constructs with or without porous structure, but there was a higher magnitude with 
increased porosity (Fig. 6C). Collectively, these results demonstrate that metabolically active 
3D bioprinted BAP constructs were achievable, and they are affected by matrix stiffness and 
porosity.
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4. Discussion
Obesity and its related metabolic disorders, such as T2DM, are significant medical concerns 
due to their far reaching effects on the health of individuals and the cost of treating these 
health complications [45–47]. To date, there are no safe and long-lasting anti-obesity 
approaches, so new methods of treating obesity and its related diseases are important in the 
ultimate effectiveness of treatment. Utilizing BAT, which uses fats to modulate energy 
expenditure, might be a promising technique for treating obesity. Several studies have 
demonstrated that mice BAT transplantation into the visceral cavity improved glucose 
tolerance, increased insulin sensitivity, and lowered body weight [48,49]. In addition, Yang 
et al. reported that murine adipose derived stromal cells were successfully differentiated into 
mature adipocytes with BAT pheno-type and function within 3D hydrogels [50]. For WA, 
3D culture has been demonstrated to promote adipogenesis and adipokine secretion 
compared to 2D culture [51,52]. It has also been demonstrated that a porous structure could 
improve the cell viability in vitro and promote cell ingrowth and integration in vivo [35,53]. 
However, it is still unclear how microenvironments affect human thermogenic brown 
adipogenesis and how to generate engineered BAT with clinically relevant size and function. 
In our current study, we first evaluated the effects of EGM medium exposure on brown 
adipogenesis of human BA. We then implemented 3D bioprinting to control the 
physicochemical properties of hydro-gel based bioinks and encapsulated both brown and 
white adipose cells to generate engineered constructs.
BAT is among the most vascularized tissues in the body, and the grade of vascularization 
determines its ability for lipid consumption and its thermogenic function [54,55]. Our 
current study demonstrated that exposure to EGM promoted brown adipogenesis of human 
BAP. Similarly, Hafner et al. demonstrated that EGM conditioning induced the formation of 
multilocular adipocytes and facilitated the differentiation of human induced pluripotent stem 
cells (hiPSC) towards brown-like adipose progenitors [56]. Most likely, VEGF in the EGM 
is the major stimulator, since VEGF is highly expressed in brown preadipocytes, as well as 
the whole BAT in murine [57,58]. In addition, VEGF had other beneficial effects on murine 
brown adipocytes to promote their survival, proliferation, and maintenance of mitochondria 
[59]. Other factors in EGM, like FGF2 and insulin-like growth factor 1, may also play an 
important role. Therefore, further study is required in the future to decouple the effects of 
different growth factors.
Compared to 2D culture systems, 3D hydrogel based culture systems better retain the 
characteristics of the depot of origin and promote the adipogenic differentiation of 
adipogenic progenitor and stromal cells [51,60]. Both HA and gelatin have been widely used 
as adipose tissue engineering biomaterials [24,61,62]. HA is also commonly used as a 
dermal and adipose filler to improve appearance and to correct deformities and loss of 
volume [63,64]. Our results showed that 3D Me-HA/Me-Gel hydrogel based bioinks also 
facilitated spontaneous adipogenesis of white and brown progenitor cells without exogenous 
induction. We tuned the stiffness and structure of bioprinted constructs by varying the 
photocrosslinking time and printing pattern. The stiffness of the soft bioprinted constructs 
(~2 kPa) was controlled to be within the physiological range of native adipose tissue (~2–4 
kPa) [33,65], whereas the stiffness for the stiff constructs (both solid and porous, ~ 9 kPa) 
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was within the low range of muscle (~8–17 kPa) [66,67]. As expected, soft gel condition 
promoted white adipogenesis. However, for brown adipogenesis, stiff constructs promoted 
glucose uptake. This is probably because BA originate from the myogenic lineage of Myf5 
positive progenitor cells, and thus the microenvironments with some characteristics of 
muscle can facilitate brown adipogenesis and subsequent metabolic activation. The porous 
structure increased both white and brown adipogenic gene expression and insulin mediated 
glucose uptake. These results demonstrated that nutrition perfusion and exchange of 
metabolic waste are important for adipogenic differentiation. Similarly, other studies have 
showed that high porosity and secondary level of pores increased adipogenic gene 
expression and intracellular lipid accumulation [68]. In addition, it was found that the 
perfusion-based culture conditions promoted faster growth of WAP and stimulated greater 
adipogenesis compared to static culture condition [69].
3D bioprinting allows the fabrication of constructs with arbitrary geometries and mechanical 
and biological heterogeneity [70,71]. Although precise geometries for adipose tissue 
engineering and brown fat fabrication are not necessary, the implementation of 3D 
bioprinting in this current study enabled the generation of a porous structure within the 
clinically relevant-sized constructs. In addition, 3D bioprinting supports the application of 
multiple cell types and bioinks by using multiple bioprinting heads. This will allow us to 
further incorporate other cells, like endothelial cells and other adipovascular related cells 
(e.g. smooth muscle cells and pericytes), to promote vascularization, since BAT is highly 
vascularized. For future in vivo applications, the stiffness and structure of adipose tissue 
constructs, as well as vascularization, should be regulated to maximize the brown adipogenic 
differentiation of BA and the metabolic functions of engineered BAT. Thus, 3D bioprinted 
BAT are promising candidates to treat obesity and other metabolism related disorders.
5. Conclusions
We pre-exposed human BAP to EGM and found that there was an increased expression of 
brown adipocyte markers, thus showing that it promoted their potential for conversion into 
metabolically active, human brown adipocytes. Once these favorable growing conditions 
were established, we evaluated the effect of a tunable, 3D bioprinted hydrogel matrix on 
encapsulated white and brown adipocytes. We 3D bioprinted the Me-HA/Me-Gel hydrogels 
with encapsulated WAP or BAP into soft, stiff, and stiff, porous discs. It was found that all 
three types had high WAP and BAP viability. For white adipogenesis, analysis using qPCR 
showed that the soft, solid and stiff, porous gels in IM had higher levels of white adipogenic 
gene expression than the stiff, solid gels and their GM counterparts. In a similar manner, we 
tested for brown adipogensis in the 3D bioprinted constructs. Staining showed the ability for 
lipid production in all of the gels, which the ones in IM having better production than the 
constructs in GM. Compared to the WAP laden gels, the BAP laden constructs in IM had 
higher levels brown adipose markers, with the bioprinted stiff and porous constructs showing 
the highest brown adipose gene expression and the soft constructs showing the lowest. The 
BAP constructs had much higher levels of glucose uptake than their WAP counterparts. The 
stiff BAP constructs had higher glucose uptake, with the porous ones being the highest. The 
constructs also supported insulin stimulated glucose uptake, and the porous structures had 
the highest uptake. Altogether, this work showed that the tunable, 3D bio-printed hydrogel 
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environments support viable adipocytes and adipogenesis, while allowing for metabolically 
active brown adipose constructs that are affected the matrix stiffness and porosity.
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Statement of Significance
One promising strategy for the treatment or prevention of obesity-mediated health 
complications is augmenting brown adipose tissues (BAT), which is a specialized fat that 
actively dissipate energy in the form of heat and maintain energy balance. In this study, 
we determined how pre-exposing human brown adi-pose progenitors (BAP) to 
angiogenic factors in 2D and how bioprinted microenvironments in 3D affected brown 
adipogenic differentiation and metabolic activity. We demonstrated that white and brown 
adipo-genesis, and thermogenesis were regulated by tuning the bioprintable matrix 
stiffness and construct structure. This study not only unveils the interaction between BAP 
and 3D physiological microenvironments, but also presents a novel tissue engineered 
strategy to manage obesity and other related metabolic disorders.
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Fig. 1. 
Pre-exposure to angiogenic factors promoted the brown-adipogenic potential of human BAP. 
(A) qPCR analysis of Ucp1, Zic1, Vegfr1, Pgc1a and Hdac1; (B) Protein levels of UCP1, 
HDAC1, histone3, and α-actin as a loading control (n = 4 per group); (C) Oxygen 
consumption rate (OCR) by Seahorse XF analyzer; (D) Brown-specific miRNA levels of 
miR-30b, 193b, 365 and 378. U6 small nuclear RNA2 (RNU6–2) was used as a reference (n 
= 4–5 per group), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Fig. 2. 
The tunability of the bioprinted hydrogel constructs allows for varying physical properties 
and surface areas. (A) Multiple bioprinting patterns and crosslinking times creates different 
geometry and stiffness (Soft = UV crosslinking for 30 s, Stiff = UV crosslinking for 90 s, 
Solid = bioprinted constructs with solid structure, Porous = bioprinted constructs with 
porous structure); (B) Compressive modulus of the different hydrogel constructs; n = 5–6; 
**p < 0.01; (C) Typical SEM and optical micrographs.
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Fig. 3. 
Live/dead staining of the three types of hydrogel constructs shows the cell viability after 
induction. (A) Hydrogel constructs with WAP encapsulated; (B) Hydrogel constructs with 
BAP encapsulated; (C) Semi-quantitative measurement of cell viability based on Live/Dead 
images (n = 6).
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Fig. 4. 
Lipid production of white adipocytes across all constructs in IM and soft constructs in GM. 
(A) Bodipy staining for lipids and nuclear staining (scale bar, 100 μm); (B) Size and size 
distribution of the single lipid droplets; (more than 100 lipid droplets from at least three IF 
images); (C) Lipid density (calculated by comparing total lipid area with total cells in the 
images, n = 5–6 images); (D) qPCR analysis of white adipogenesis related genes expression. 
Relative gene expression is presented as normalized to 18S and expressed relative to soft, 
solid constructs in GM. (n = 3, *p < 0.05, **p < 0.01).
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Fig. 5. 
Staining and gene expression across all constructs in IM and soft constructs in GM. (A) 
Staining of brown adipose constructs. Bodipy staining for lipids, UCP-1 staining for a brown 
adipogenic marker, and nuclear staining; (B, C) qPCR analysis of brown adipogenesis and 
inflammation related genes expression. (B) Relative gene expression is presented as 
normalized to 18 s and expressed relative to soft, solid constructs with WA in GM. (n = 3, 
bars that do not share letters are significantly different from each other, **p < 0.01, # 
indicates p < 0.05 comparing to soft, solid constructs with WA, & indicates no significant 
difference comparing to stiff, solid constructs with BA); (C) Relative gene expression is 
presented as normalized to 18 s and expressed relative to soft, solid constructs with BA in 
IM. (n = 3, *p < 0.05).
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Fig. 6. 
Hydrogel stiffness and porosity altered metabolic function of 3D bioprinted BAP laden 
constructs. Roughly 5 × 106 of WAP and BAP were bioprinted in differential bioink and 
bioprinting structure conditions. Glucose uptake was measured by using 3H-2-deoxy glucose 
(DOG) as a metabolic tracer. (A) Basal levels of 2-DOG uptake in WA and BA cultures; (n = 
4, **p < 0.01, ***p < 0.001), (B) Oxygen consumption rate in BA cultures in stiff or stiff-
porous hydrogel scaffolds (n = 4 per group). No cell control was used as a negative control. 
(C) 2-DOG uptake in the presence and absence of insulin (100 nM) for 90 min. Data 
normalized by protein levels and expressed as cpm/g protein/per 3D bioprinted construct (n 
= 4, *p < 0.05, **p < 0.01).
Kuss et al. Page 21
Acta Biomater. Author manuscript; available in PMC 2018 July 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
